Related Experiment Video
Updated: May 30, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
[Clinical utility of specialized immunologic testing in rheumatology in a secondary level hospital in Mexico]
Israel David Campos-González1, Martha Eva Viveros, Mario H Cardiel
1Unidad de Investigación. Hospital General Dr. Miguel Silva. Morelia. Michoacán. México.
Introduction:
Laboratory tests have an important role in rheumatology for evaluation, diagnosis and follow up in several diseases. Specialized tests such as antinuclear antibodies (ANA), anti single or double stranded DNA antibodies (anti DNA) and anticardiolipin antibodies (AcACL) are frequently used and its diagnostic performance is well known in tertiary care centers. Our setting is a secondary care center that implemented these tests two years ago. After one year of implementation, we decided to evaluate the frequency of use, who orders these tests, and their diagnostic properties for the diagnosis of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APLS). PATIENST AND METHOD: All patients with clinical charts and a request for these tests were evaluated from September 1, 2005 to June 30, 2006. These evaluations were done prospectively by a single, trained evaluator following a standardized format looking at pretest clinical information such as pretest diagnosis, physician's level of training, service and posttest results as well as therapeutic changes after results.
Statistical Analysis:
descriptive statistics and 2 by 2 tables to estimate diagnostic performance of most common indications.
Results:
Two hundred and eighty six requests were reviewed and only 157 were evaluated. Rheumatology and Internal Medicine services sent 63 and 31 requests for these tests respectively. Diagnostic properties of ANA for SLE were sensitivity (sen) 70%, specificity (spec): 92%, positive predictive value (PPV): 81%, negative predictive value (NPP): 86%, positive likelihood ratio (PLR): 8.73 and negative likelihood ratio (NLR): 0.33. Anti double stranded DNA Sen: 78%, spec: 50%, PPV: 80%, NPP: 46%, PLR: 1.56, NLR: 0.44. ACACL Sen: 78% spec: 92%, PPV: 78%, NPV 92%, PLR: 10, NLR 0.24.
Conclusions:
These specialized tests are not frequently used in our setting. Their diagnostic properties are not as accurate as those published in medical literature. Guidelines are needed in our hospital to improve their diagnostic performance.
More Related Videos
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
16:07Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests